Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation

Treatment and hematopoietic SCT in aplastic anemia

(2012) J R Passweg et al.   BONE MARROW TRANSPLANTATION

Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience

(2012) Sujith Samarasinghe et al.   BRITISH JOURNAL OF HAEMATOLOGY

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

(2012) A. Bacigalupo et al.   HAEMATOLOGICA

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

(2011) J. C. Marsh et al.   BLOOD

Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia

(2011) J. E. Sanders et al.   BLOOD

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia

(2011) M. Eapen et al.   BLOOD

Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning

(2011) J. Konopacki et al.   HAEMATOLOGICA

Outcome of Allogeneic Hematopoietic Cell Transplantation from HLA-Identical Siblings for Severe Aplastic Anemia in Patients Over 40 Years of Age

(2010) Dario Sangiolo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Successful Engraftment with Fludarabine, Cyclophosphamide, and Thymoglobulin Conditioning Regimen in Unrelated Transplantation for Severe Aplastic Anemia: A Phase II Prospective Multicenter Study

(2010) Hyoung Jin Kang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia

(2010) H Yagasaki et al.   BONE MARROW TRANSPLANTATION

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

(2010) V. Gupta et al.   HAEMATOLOGICA

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party

(2010) A. Bacigalupo et al.   HAEMATOLOGICA

Guidelines for the diagnosis and management of aplastic anaemia

(2009) Judith C. W. Marsh et al.   BRITISH JOURNAL OF HAEMATOLOGY

Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen

(2009) S. Maury et al.   HAEMATOLOGICA

Thyroid function following hematopoietic cell transplantation in children: 30 years' experience

(2008) J. E. Sanders et al.   BLOOD